Please provide your email address to receive an email when new articles are posted on . An ongoing study showed improvements in SSc severity, disease-related pain, Raynaud’s symptoms and ...

Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.

Millions of people around the world take medication every day to control high blood pressure and reduce their risk of heart ...

High blood pressure is one of the most common health problems in the world. According to the World Health Organization, ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

Treatment for coronary artery disease (CAD) involves lifestyle changes alongside medications such as antiplatelets and statins. There are many different medications to treat CAD. Treatment for CAD is ...

Timna Agur, MD, from Tel-Aviv University in Israel, and colleagues conducted a retrospective cohort study using Clalit Health Services data for 2016 to 2021 to examine the impact of DCCB on kidney ...

Dihydropyridine calcium channel blockers may be linked to worse kidney outcomes for patients with type 2 diabetes, according to study data presented at the European Renal Association Congress in ...